Fisher And Paykel Healthcare

In 2025, Fisher & Paykel Healthcare, headquartered in New Zealand, reported total carbon emissions of approximately 280,745,000 kg CO2e. This figure includes 2,295,000 kg CO2e from Scope 1 emissions, 12,406,000 kg CO2e from Scope 2 emissions (market-based), and 266,044,000 kg CO2e from Scope 3 emissions. The company has set an ambitious target to achieve a 67% reduction in its Scope 1 and 2 greenhouse gas emissions by 2034, using a 2019 baseline of 11,198 metric tons CO2e.

In 2024, the total emissions were approximately 255,686,000 kg CO2e, with Scope 1 emissions at 2,013,000 kg CO2e, Scope 2 emissions at 12,253,000 kg CO2e (market-based), and Scope 3 emissions at 241,420,000 kg CO2e. The previous year, 2023, saw total emissions of about 324,131,000 kg CO2e, comprising 2,329,000 kg CO2e from Scope 1, 11,105,000 kg CO2e from Scope 2 (market-based), and 310,697,000 kg CO2e from Scope 3.

Fisher & Paykel Healthcare is committed to ensuring that 87% of its suppliers, by spend, covering purchased goods and services and the use of sold products, will have science-based targets by 2024. This commitment aligns with their broader sustainability goals and reflects their dedication to reducing their overall carbon footprint in the healthcare equipment and supplies sector.